Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

United States Long Acting Analgesic Market 2017-2021 - Size, Trends & Forecasts Report - Research and Markets

Research and Markets
Posted on: 04 Dec 17

The "The US Long Acting Analgesic Market: Size, Trends & Forecasts (2017-2021)" report has been added to Research and Markets' offering.

The US Long Acting Analgesic Market: Size, Trends & Forecasts (2017-2021), provides analysis of the US analgesics market, with detailed analysis of market size in terms of number of procedures, segments, etc. Further, an analysis of the long acting analgesics in terms of penetration has been done for EXPAREL and HTX-011 along with its respective sales analysis. Under competitive landscape, players in the US analgesics market (both short and long acting analgesics) have been compared on the basis of market capitalization.

Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the long acting analgesics market in the US has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The US long acting analgesic market is expected to increase at high growth rates during the forecast period (2017-2021). The US long acting analgesic market is supported by various growth factors such as increasing elderly population, increase in use of non opioid analgesics especially in orthopedic procedures and disadvantages of opioids.

However, issues faced by PCRX in the commercialization of EXPAREL is major challenge faced by the market. Upsurge in research and development expenses, low penetration of currently used local analgesics, evolution of multimodal analgesics and long acting analgesics in pipeline are some of the latest trends existing in the market.

Pacira Pharmaceutical Inc., Heron Therapeutics Inc. and Fresenius Group are some of the key players operating in the US long acting analgesics market whose company profiling is done in the report. In this segment of the report, business overview, financial overview and the business strategies of the companies are provided.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. The US Market Analysis

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

  • Fresenius Group
  • Heron Therapeutics Inc.
  • Pacira Pharmaceutical Plc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 04/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.